
Jeff Brown’s 2021 Predictions: A “Second Crop” of CRISPR Profits Is Coming in 2021
Jeff is more bullish on CRISPR than ever. And he believes there’s a “second crop” of CRISPR profits that...
Editor, The Bleeding Edge, The Near Future Report, Exponential Tech Investor, Neural Net Profits, and Brownstone Unlimited
Jeff Brown is the founder and chief investment analyst for Brownstone Research. Before founding Brownstone Research, Jeff spent 25 years as a high-technology executive. He worked as an executive level for some of the best technology companies in the world, like Qualcomm, NXP Semiconductors, and Juniper Networks.
As an active and successful angel investor in early stage technology companies, he has access to information the public never sees. He is on the front line, in the field, seeing things months, if not years, before the mass market becomes aware.
Jeff has a wide range of technology industry experience. From semiconductors to mobility… to broadcasting and video technology… to technology infrastructure… to IT networking and security… to automotive and even consumer electronics… he’s done it all.
He has built organizations from the ground up and run divisions of companies generating hundreds of millions in revenue a year.
Though he was born, educated, and began his career in America, he spent two decades living and working in international markets, with much of that time spent in Tokyo, Japan. That gives him a unique global perspective on business, investing, and analysis.
Jeff earned his undergraduate degree in aeronautical and astronautical engineering from Purdue University. He also earned his master’s degree in management from the London Business School. Jeff is also an alumnus of Yale University’s School of Management.
In addition to formal degrees, Jeff has professional certificates from MIT, Stanford, UC Berkeley’s School of Law, and the National University of Singapore.
Jeff is an active board member and adviser to several companies and an active angel investor.
Today, Jeff uses his technology, business, finance, and investing expertise to help everyday investors discover companies on the verge of exponential growth.
Jeff is more bullish on CRISPR than ever. And he believes there’s a “second crop” of CRISPR profits that...
Today, we’re continuing our 2021 prediction series with Jeff. And we’ll be talking about a topic that longtime readers...
Let’s assume Joe Biden takes office on the 20th of January. What does that mean for the high-technology sector?
Read on for the lessons the world must learn from this pandemic, and see why Jeff believes his coverage...
In mid-December, I asked Jeff to sit down to revisit his predictions and to look forward to the new...
Protein folding is a very fascinating topic with big implications for biotechnology and medicine. And there’s one key discovery...
The days of learning a trade, working at your trade for 40 years, and then retiring are over. The...
Project Titan is the name of Apple’s secretive self-driving car initiative. Though it has kept this project quiet over...
The U.S. Air Force just revealed that it is developing AI-controlled drones for combat missions. The program is ominously...